National and Kapodistrian University of Athens
Νευρογενή-αγγειοδραστικά πεπτίδια στη συστηματική κυκλοφορία υπερτασικών ασθενών: επίδραση της αντιϋπερτασικής αγωγής
Abstract
dc:descriptionAIM: To evaluate the effect of antihypertensive treatment on plasma PACAP-38 levels, in patients with essential hypertension (EH). METHODS: Plasma PACAP-38 levels were calculated, using RIA, in forty nine patients with EH and ten healthy volunteers (HS). Fourteen patients were treated with moxonidine (MOX), 14 patients with perindoprilat (PER), 12 with felodipine (FEL) and 9 with diltiazem (DILT), as monotherapy for 6 months. RESULTS: Blood pressure (BP) was found to be normalized after the treatment period in all groups. Plasma PACAP-38 levels were significantly higher in HS than the corresponding levels of hypertensive patients, at baseline. Significantly elevated plasma PACAP-38 levels was found in the groups of (MOX), (FEL) and (DILT) but no in the group of (PER), after the treatment period. CONCLUSION: Antihypertensive treatment with (MOX), (FEL) and (DILT), but not with (PER) resulted in significant elevation of plasma PACAP-38 levels. The neuroprotective action of these drugs, seems to be based on the mechanism of their action.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Eleusiniotis, Ioannis
- Ελευσινιώτης, Ιωάννης
Subjects
dc:subject × 20- Υπέρταση
- Αντιυπερτασική αγωγή
- Νευροπροστασία
- Νευροπεπτίδια
- Μοξονιδίνη
- Περινδοπρίλη
- Φελοδιπίνη
- Διλτιαζέμη
- Hypertension
- Antihypertensive treatment
- Neuroprotection
- Neuropeptides
- Moxonidine
- Perindoprilat
- Calcium antagonists
- Pituitary adenylate cyclase activating polypeptide (PACAP)
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22415